Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®. A Multi-centre, Open-label, Non-interventional Post-marketing Study to Investigate the Long-term Safety and Effectiveness of Ozempic® (Semaglutide) in Japanese Patients With Type 2 Diabetes Mellitus Under Normal Clinical Practice Condition
| Verified date | November 2023 |
| Source | Novo Nordisk A/S |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
The purpose of this study is to assess the safety of long-term treatment with Ozempic® in patients with type 2 diabetes mellitus. People will get Ozempic® as prescribed by their doctor. People will be in this study about 3 years. People above the age of 18 will be asked to fill in the quality of life (QOL) questionnaire (the QOL questionnaire is for the assessment of the influence of diabetes treatment on people's life). There is a possibility that people's blood sample would be provided to Novo Nordisk from their doctors in case of severe allergic reaction that might be caused by Ozempic®.
| Status | Enrolling by invitation |
| Enrollment | 3000 |
| Est. completion date | July 31, 2025 |
| Est. primary completion date | July 31, 2025 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | N/A and older |
| Eligibility | Inclusion Criteria: - Signed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol). - The decision to initiate treatment with commercially available Ozempic® has been made by the patient/Legally Acceptable Representative (LAR) and the treating physician before and independently from the decision to include the patient in this study. - Patients with Diabetes Mellitus, Type 2 (T2DM) who the physician has decided to start treatment with Ozempic®. - Male or female, no age limitation. Exclusion Criteria: - Previous participation in this study. Participation is defined as having given informed consent in this study. - Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation. - Patients who fall under contraindications to the label. - Patients who are or have previously been treated with Ozempic®. - Female who is pregnant, breast-feeding or intends to become pregnant. |
| Country | Name | City | State |
|---|---|---|---|
| Japan | Novo Nordisk Investigational Site | Aichi | |
| Japan | Novo Nordisk Investigational Site | Aichi | |
| Japan | Novo Nordisk Investigational Site | Aichi | |
| Japan | Novo Nordisk Investigational Site | Aichi | |
| Japan | Novo Nordisk Investigational Site | Aichi | |
| Japan | Novo Nordisk Investigational Site | Aichi | |
| Japan | Novo Nordisk Investigational Site | Aichi | |
| Japan | Novo Nordisk Investigational Site | Aichi | |
| Japan | Novo Nordisk Investigational Site | Aichi | |
| Japan | Novo Nordisk Investigational Site | Aichi | |
| Japan | Novo Nordisk Investigational Site | Aichi | |
| Japan | Novo Nordisk Investigational Site | Aichi | |
| Japan | Novo Nordisk Investigational Site | Aichi | |
| Japan | Novo Nordisk Investigational Site | Aichi | |
| Japan | Novo Nordisk Investigational Site | Aichi | |
| Japan | Novo Nordisk Investigational Site | Aichi | |
| Japan | Novo Nordisk Investigational Site | Aichi | |
| Japan | Novo Nordisk Investigational Site | Aichi | |
| Japan | Novo Nordisk Investigational Site | Akita | |
| Japan | Novo Nordisk Investigational Site | Akita | |
| Japan | Novo Nordisk Investigational Site | Akita | |
| Japan | Novo Nordisk Investigational Site | Aomori | |
| Japan | Novo Nordisk Investigational Site | Aomori | |
| Japan | Novo Nordisk Investigational Site | Arakawa-ku, Tokyo | |
| Japan | Novo Nordisk Investigational Site | Asahikawa-shi, Hokkaido | |
| Japan | Novo Nordisk Investigational Site | Chiba | |
| Japan | Novo Nordisk Investigational Site | Chiba | |
| Japan | Novo Nordisk Investigational Site | Chiba | |
| Japan | Novo Nordisk Investigational Site | Chiba | |
| Japan | Novo Nordisk Investigational Site | Chiba | |
| Japan | Novo Nordisk Investigational Site | Chiba | |
| Japan | Novo Nordisk Investigational Site | Chiba | |
| Japan | Novo Nordisk Investigational Site | Chiba | |
| Japan | Novo Nordisk Investigational Site | Chiba | |
| Japan | Novo Nordisk Investigational Site | Chiba | |
| Japan | Novo Nordisk Investigational Site | Chiba | |
| Japan | Novo Nordisk Investigational Site | Chiba | |
| Japan | Novo Nordisk Investigational Site | Chiba | |
| Japan | Novo Nordisk Investigational Site | Chiba | |
| Japan | Novo Nordisk Investigational Site | Chiba-shi, Chiba | |
| Japan | Novo Nordisk Investigational Site | Chichibu-city | |
| Japan | Novo Nordisk Investigational Site | Chitose, Hokkaido | |
| Japan | Novo Nordisk Investigational Site | Ehime | |
| Japan | Novo Nordisk Investigational Site | Ehime | |
| Japan | Novo Nordisk Investigational Site | Ehime | |
| Japan | Novo Nordisk Investigational Site | Ehime | |
| Japan | Novo Nordisk Investigational Site | Ehime | |
| Japan | Novo Nordisk Investigational Site | Ehime | |
| Japan | Novo Nordisk Investigational Site | Ehime | |
| Japan | Novo Nordisk Investigational Site | Ehime | |
| Japan | Novo Nordisk Investigational Site | Ehime | |
| Japan | Novo Nordisk Investigational Site | Ehime | |
| Japan | Novo Nordisk Investigational Site | Ehime | |
| Japan | Novo Nordisk Investigational Site | Fukui | |
| Japan | Novo Nordisk Investigational Site | Fukui-shi, Fukui | |
| Japan | Novo Nordisk Investigational Site | Fukuoka | |
| Japan | Novo Nordisk Investigational Site | Fukuoka | |
| Japan | Novo Nordisk Investigational Site | Fukuoka | |
| Japan | Novo Nordisk Investigational Site | Fukuoka | |
| Japan | Novo Nordisk Investigational Site | Fukuoka | |
| Japan | Novo Nordisk Investigational Site | Fukuoka | |
| Japan | Novo Nordisk Investigational Site | Fukuoka | |
| Japan | Novo Nordisk Investigational Site | Fukuoka | |
| Japan | Novo Nordisk Investigational Site | Fukuoka | |
| Japan | Novo Nordisk Investigational Site | Fukuoka | |
| Japan | Novo Nordisk Investigational Site | Fukuoka | |
| Japan | Novo Nordisk Investigational Site | Fukuoka | |
| Japan | Novo Nordisk Investigational Site | Fukuoka | |
| Japan | Novo Nordisk Investigational Site | Fukuoka | |
| Japan | Novo Nordisk Investigational Site | Fukuoka | |
| Japan | Novo Nordisk Investigational Site | Fukuoka | |
| Japan | Novo Nordisk Investigational Site | Fukuoka | |
| Japan | Novo Nordisk Investigational Site | Fukuoka | |
| Japan | Novo Nordisk Investigational Site | Fukuoka-shi, Fukuoka | |
| Japan | Novo Nordisk Investigational Site | Fukushima | |
| Japan | Novo Nordisk Investigational Site | Fukushima | |
| Japan | Novo Nordisk Investigational Site | Fukushima | |
| Japan | Novo Nordisk Investigational Site | Fukushima-shi, Fukushima | |
| Japan | Novo Nordisk Investigational Site | Gifu | |
| Japan | Novo Nordisk Investigational Site | Gifu | |
| Japan | Novo Nordisk Investigational Site | Gifu | |
| Japan | Novo Nordisk Investigational Site | Gifu | |
| Japan | Novo Nordisk Investigational Site | Gifu | |
| Japan | Novo Nordisk Investigational Site | Gifu | |
| Japan | Novo Nordisk Investigational Site | Gifu-shi, Gifu | |
| Japan | Novo Nordisk Investigational Site | Gumma | |
| Japan | Novo Nordisk Investigational Site | Gumma | |
| Japan | Novo Nordisk Investigational Site | Gumma | |
| Japan | Novo Nordisk Investigational Site | Gumma | |
| Japan | Novo Nordisk Investigational Site | Gunma | |
| Japan | Novo Nordisk Investigational Site | Gunma | |
| Japan | Novo Nordisk Investigational Site | Gunma | |
| Japan | Novo Nordisk Investigational Site | Higashiosaka-shi, Osaka | |
| Japan | Novo Nordisk Investigational Site | Hiroshima | |
| Japan | Novo Nordisk Investigational Site | Hiroshima | |
| Japan | Novo Nordisk Investigational Site | Hiroshima | |
| Japan | Novo Nordisk Investigational Site | Hiroshima | |
| Japan | Novo Nordisk Investigational Site | Hiroshima | |
| Japan | Novo Nordisk Investigational Site | Hiroshima | |
| Japan | Novo Nordisk Investigational Site | Hokkaido | |
| Japan | Novo Nordisk Investigational Site | Hokkaido | |
| Japan | Novo Nordisk Investigational Site | Hokkaido | |
| Japan | Novo Nordisk Investigational Site | Hokkaido | |
| Japan | Novo Nordisk Investigational Site | Hokkaido | |
| Japan | Novo Nordisk Investigational Site | Hokkaido | |
| Japan | Novo Nordisk Investigational Site | Hokkaido | |
| Japan | Novo Nordisk Investigational Site | Hokkaido | |
| Japan | Novo Nordisk Investigational Site | Hokkaido | |
| Japan | Novo Nordisk Investigational Site | Hokkaido | |
| Japan | Novo Nordisk Investigational Site | Hokkaido | |
| Japan | Novo Nordisk Investigational Site | Hokkaido | |
| Japan | Novo Nordisk Investigational Site | Hokkaido | |
| Japan | Novo Nordisk Investigational Site | Hokkaido | |
| Japan | Novo Nordisk Investigational Site | Hosu-gun, Ishikawa | |
| Japan | Novo Nordisk Investigational Site | Hyogo | |
| Japan | Novo Nordisk Investigational Site | Hyogo | |
| Japan | Novo Nordisk Investigational Site | Hyogo | |
| Japan | Novo Nordisk Investigational Site | Hyogo | |
| Japan | Novo Nordisk Investigational Site | Hyogo | |
| Japan | Novo Nordisk Investigational Site | Hyogo | |
| Japan | Novo Nordisk Investigational Site | Hyogo | |
| Japan | Novo Nordisk Investigational Site | Hyogo | |
| Japan | Novo Nordisk Investigational Site | Hyogo | |
| Japan | Novo Nordisk Investigational Site | Hyogo | |
| Japan | Novo Nordisk Investigational Site | Hyogo | |
| Japan | Novo Nordisk Investigational Site | Hyogo | |
| Japan | Novo Nordisk Investigational Site | Hyogo | |
| Japan | Novo Nordisk Investigational Site | Hyogo | |
| Japan | Novo Nordisk Investigational Site | Hyogo | |
| Japan | Novo Nordisk Investigational Site | Hyogo | |
| Japan | Novo Nordisk Investigational Site | Hyogo | |
| Japan | Novo Nordisk Investigational Site | Hyogo | |
| Japan | Novo Nordisk Investigational Site | Hyogo | |
| Japan | Novo Nordisk Investigational Site | Hyogo | |
| Japan | Novo Nordisk Investigational Site | Hyogo | |
| Japan | Novo Nordisk Investigational Site | Hyogo | |
| Japan | Novo Nordisk Investigational Site | Hyogogoken | |
| Japan | Novo Nordisk Investigational Site | Ibaraki | |
| Japan | Novo Nordisk Investigational Site | Ibaraki | |
| Japan | Novo Nordisk Investigational Site | Ibaraki | |
| Japan | Novo Nordisk Investigational Site | Ibaraki | |
| Japan | Novo Nordisk Investigational Site | Ibaraki | |
| Japan | Novo Nordisk Investigational Site | Ibaraki | |
| Japan | Novo Nordisk Investigational Site | Ibaraki | |
| Japan | Novo Nordisk Investigational Site | Ibaraki | |
| Japan | Novo Nordisk Investigational Site | Imizu-shi | Toyama, Japan |
| Japan | Novo Nordisk Investigational Site | Iruma-shi, Saitama | |
| Japan | Novo Nordisk Investigational Site | Ishikawa | |
| Japan | Novo Nordisk Investigational Site | Ishikawa | |
| Japan | Novo Nordisk Investigational Site | Iwate | |
| Japan | Novo Nordisk Investigational Site | Iwate | |
| Japan | Novo Nordisk Investigational Site | Iwate | |
| Japan | Novo Nordisk Investigational Site | Iwate | |
| Japan | Novo Nordisk Investigational Site | Izumisano-shi | Osaka, Japan |
| Japan | Novo Nordisk Investigational Site | Kagawa | |
| Japan | Novo Nordisk Investigational Site | Kagawa | |
| Japan | Novo Nordisk Investigational Site | Kagawa | |
| Japan | Novo Nordisk Investigational Site | Kagawa | |
| Japan | Novo Nordisk Investigational Site | Kagawa | |
| Japan | Novo Nordisk Investigational Site | Kagawa | |
| Japan | Novo Nordisk Investigational Site | Kagoshima | |
| Japan | Novo Nordisk Investigational Site | Kagoshima | |
| Japan | Novo Nordisk Investigational Site | Kagoshima | |
| Japan | Novo Nordisk Investigational Site | Kagoshima | |
| Japan | Novo Nordisk Investigational Site | Kagoshima | |
| Japan | Novo Nordisk Investigational Site | Kagoshima | |
| Japan | Novo Nordisk Investigational Site | Kagoshima | |
| Japan | Novo Nordisk Investigational Site | Kagoshima-shi, Kagoshima | |
| Japan | Novo Nordisk Investigational Site | Kamakura-shi | Kanagawa, Japan |
| Japan | Novo Nordisk Investigational Site | Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Kawagoe-shi | Saitama, Japan |
| Japan | Novo Nordisk Investigational Site | Kawasaki-shi | Kanagawa, Japan |
| Japan | Novo Nordisk Investigational Site | Kisarazu-shi, Chiba | |
| Japan | Novo Nordisk Investigational Site | Kobe, Hyogo | |
| Japan | Novo Nordisk Investigational Site | Kochi | |
| Japan | Novo Nordisk Investigational Site | Koriyama-shi | Fukushima, Japan |
| Japan | Novo Nordisk Investigational Site | Koshigaya-shi,Saitama | |
| Japan | Novo Nordisk Investigational Site | Kumamoto | |
| Japan | Novo Nordisk Investigational Site | Kumamoto | |
| Japan | Novo Nordisk Investigational Site | Kumamoto-shi | Kumamoto, Japan |
| Japan | Novo Nordisk Investigational Site | Kyoto | |
| Japan | Novo Nordisk Investigational Site | Kyoto | |
| Japan | Novo Nordisk Investigational Site | Kyoto | |
| Japan | Novo Nordisk Investigational Site | Kyoto | |
| Japan | Novo Nordisk Investigational Site | Kyoto | |
| Japan | Novo Nordisk Investigational Site | Kyoto | |
| Japan | Novo Nordisk Investigational Site | Kyoto | |
| Japan | Novo Nordisk Investigational Site | Kyoto | |
| Japan | Novo Nordisk Investigational Site | Mie | |
| Japan | Novo Nordisk Investigational Site | Mie | |
| Japan | Novo Nordisk Investigational Site | Mie | |
| Japan | Novo Nordisk Investigational Site | Mie | |
| Japan | Novo Nordisk Investigational Site | Minato-ku | Tokyo, Japan |
| Japan | Novo Nordisk Investigational Site | Mitaka-shi, Tokyo | |
| Japan | Novo Nordisk Investigational Site | Miura-shi, Kanagawa | |
| Japan | Novo Nordisk Investigational Site | Miyagi | |
| Japan | Novo Nordisk Investigational Site | Miyagi | |
| Japan | Novo Nordisk Investigational Site | Miyagi | |
| Japan | Novo Nordisk Investigational Site | Miyagi | |
| Japan | Novo Nordisk Investigational Site | Miyazaki | |
| Japan | Novo Nordisk Investigational Site | Miyazaki | |
| Japan | Novo Nordisk Investigational Site | Miyazaki | |
| Japan | Novo Nordisk Investigational Site | Miyazaki | |
| Japan | Novo Nordisk Investigational Site | Miyazaki-shi | Miyazaki, Japan |
| Japan | Novo Nordisk Investigational Site | Muroran-shi, Hokkaido | |
| Japan | Novo Nordisk Investigational Site | Nagano | |
| Japan | Novo Nordisk Investigational Site | Nagano | |
| Japan | Novo Nordisk Investigational Site | Nagano | |
| Japan | Novo Nordisk Investigational Site | Nagano | |
| Japan | Novo Nordisk Investigational Site | Nagano | |
| Japan | Novo Nordisk Investigational Site | Nagano | |
| Japan | Novo Nordisk Investigational Site | Nagasaki | |
| Japan | Novo Nordisk Investigational Site | Nagasaki | |
| Japan | Novo Nordisk Investigational Site | Nagasaki | |
| Japan | Novo Nordisk Investigational Site | Nagasaki | |
| Japan | Novo Nordisk Investigational Site | Nagasaki | |
| Japan | Novo Nordisk Investigational Site | Nagasaki | |
| Japan | Novo Nordisk Investigational Site | Nagasaki | |
| Japan | Novo Nordisk Investigational Site | Nagasaki | |
| Japan | Novo Nordisk Investigational Site | Nara | |
| Japan | Novo Nordisk Investigational Site | Nara | |
| Japan | Novo Nordisk Investigational Site | Nara | |
| Japan | Novo Nordisk Investigational Site | Nara | |
| Japan | Novo Nordisk Investigational Site | Nara | |
| Japan | Novo Nordisk Investigational Site | Nara | |
| Japan | Novo Nordisk Investigational Site | Nara | |
| Japan | Novo Nordisk Investigational Site | Nara | |
| Japan | Novo Nordisk Investigational Site | Nara | |
| Japan | Novo Nordisk Investigational Site | Niigata | |
| Japan | Novo Nordisk Investigational Site | Niigata | |
| Japan | Novo Nordisk Investigational Site | Niigata | |
| Japan | Novo Nordisk Investigational Site | Niigata | |
| Japan | Novo Nordisk Investigational Site | Niigata-shi, Niigata | |
| Japan | Novo Nordisk Investigational Site | Nishinomiya-shi, Hyogo | |
| Japan | Novo Nordisk Investigational Site | Oita | |
| Japan | Novo Nordisk Investigational Site | Oita | |
| Japan | Novo Nordisk Investigational Site | Oita | |
| Japan | Novo Nordisk Investigational Site | Oita | |
| Japan | Novo Nordisk Investigational Site | Oita | |
| Japan | Novo Nordisk Investigational Site | Oita-shi | Oita, Japan |
| Japan | Novo Nordisk Investigational Site | Okayama | |
| Japan | Novo Nordisk Investigational Site | Okayama | |
| Japan | Novo Nordisk Investigational Site | Okayama | |
| Japan | Novo Nordisk Investigational Site | Okayama | |
| Japan | Novo Nordisk Investigational Site | Okayama | |
| Japan | Novo Nordisk Investigational Site | Okayama-shi, Okayama | |
| Japan | Novo Nordisk Investigational Site | Okinawa | |
| Japan | Novo Nordisk Investigational Site | Okinawa | |
| Japan | Novo Nordisk Investigational Site | Okinawa | |
| Japan | Novo Nordisk Investigational Site | Okinawa | |
| Japan | Novo Nordisk Investigational Site | Okinawa | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka-shi, Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka-shi, Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaka-shi, Osaka | |
| Japan | Novo Nordisk Investigational Site | Osaki-shi, Miyagi | |
| Japan | Novo Nordisk Investigational Site | Ota-ku, Tokyo | |
| Japan | Novo Nordisk Investigational Site | Ota-ku, Tokyo | |
| Japan | Novo Nordisk Investigational Site | Saga | |
| Japan | Novo Nordisk Investigational Site | Saga | |
| Japan | Novo Nordisk Investigational Site | Saga | |
| Japan | Novo Nordisk Investigational Site | Saga | |
| Japan | Novo Nordisk Investigational Site | Saga | |
| Japan | Novo Nordisk Investigational Site | Saga | |
| Japan | Novo Nordisk Investigational Site | Saitama | |
| Japan | Novo Nordisk Investigational Site | Saitama | |
| Japan | Novo Nordisk Investigational Site | Saitama | |
| Japan | Novo Nordisk Investigational Site | Saitama | |
| Japan | Novo Nordisk Investigational Site | Saitama | |
| Japan | Novo Nordisk Investigational Site | Saitama | |
| Japan | Novo Nordisk Investigational Site | Saitama | |
| Japan | Novo Nordisk Investigational Site | Saitama | |
| Japan | Novo Nordisk Investigational Site | Saitama | |
| Japan | Novo Nordisk Investigational Site | Saitama | |
| Japan | Novo Nordisk Investigational Site | Saitama | |
| Japan | Novo Nordisk Investigational Site | Sendai-shi, Miyagi | |
| Japan | Novo Nordisk Investigational Site | Shiga | |
| Japan | Novo Nordisk Investigational Site | Shiga | |
| Japan | Novo Nordisk Investigational Site | Shiga | |
| Japan | Novo Nordisk Investigational Site | Shiga | |
| Japan | Novo Nordisk Investigational Site | Shimane | |
| Japan | Novo Nordisk Investigational Site | Shimane | |
| Japan | Novo Nordisk Investigational Site | Shimane | |
| Japan | Novo Nordisk Investigational Site | Shimotsuga-gun, Tochigi | |
| Japan | Novo Nordisk Investigational Site | Shimotsuke-shi, Tochigi | |
| Japan | Novo Nordisk Investigational Site | Shinjuku-ku, Tokyo | |
| Japan | Novo Nordisk Investigational Site | Shinjyuku-ku Tokyo | |
| Japan | Novo Nordisk Investigational Site | Shizuoka | |
| Japan | Novo Nordisk Investigational Site | Shizuoka | |
| Japan | Novo Nordisk Investigational Site | Shizuoka | |
| Japan | Novo Nordisk Investigational Site | Shizuoka | |
| Japan | Novo Nordisk Investigational Site | Shizuoka | |
| Japan | Novo Nordisk Investigational Site | Shizuoka | |
| Japan | Novo Nordisk Investigational Site | Shizuoka | |
| Japan | Novo Nordisk Investigational Site | Shizuoka | |
| Japan | Novo Nordisk Investigational Site | Shizuoka-city, Shizuoka | |
| Japan | Novo Nordisk Investigational Site | Soka-shi, Saitama | |
| Japan | Novo Nordisk Investigational Site | Suzaka-shi ,Nagano | |
| Japan | Novo Nordisk Investigational Site | Tamana-shi, Kumamoto | |
| Japan | Novo Nordisk Investigational Site | Tochigi | |
| Japan | Novo Nordisk Investigational Site | Tochigi | |
| Japan | Novo Nordisk Investigational Site | Tochigi | |
| Japan | Novo Nordisk Investigational Site | Tokorozawa-shi,Saitama | |
| Japan | Novo Nordisk Investigational Site | Tokushima | |
| Japan | Novo Nordisk Investigational Site | Tokushima | |
| Japan | Novo Nordisk Investigational Site | Tokushima | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tokyo | |
| Japan | Novo Nordisk Investigational Site | Tomigusuku-shi, Okinawa | |
| Japan | Novo Nordisk Investigational Site | Tottori | |
| Japan | Novo Nordisk Investigational Site | Tottori | |
| Japan | Novo Nordisk Investigational Site | Toyama | |
| Japan | Novo Nordisk Investigational Site | Toyama-shi, Toyama | |
| Japan | Novo Nordisk Investigational Site | Toyonaka-shi, Osaka | |
| Japan | Novo Nordisk Investigational Site | Wakayama | |
| Japan | Novo Nordisk Investigational Site | Yamagata | |
| Japan | Novo Nordisk Investigational Site | Yamagata | |
| Japan | Novo Nordisk Investigational Site | Yamaguchi | |
| Japan | Novo Nordisk Investigational Site | Yamaguchi | |
| Japan | Novo Nordisk Investigational Site | Yamaguchi | |
| Japan | Novo Nordisk Investigational Site | Yamanashi | |
| Japan | Novo Nordisk Investigational Site | Yamato-shi | Kanagawa |
| Japan | Novo Nordisk Investigational Site | Yanagawa-shi, Fukuoka | |
| Japan | Novo Nordisk Investigational Site | Yokohama, Kanagawa |
| Lead Sponsor | Collaborator |
|---|---|
| Novo Nordisk A/S |
Japan,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Number of adverse events (AEs) | Count | From baseline (day 0) to end of study (month 36) | |
| Secondary | Number of serious adverse reactions (SARs) | Count | From baseline (day 0) to end of study (month 36) | |
| Secondary | Number of adverse reactions (ARs) | Count | From baseline (day 0) to end of study (month 36) | |
| Secondary | Number of serious adverse events (SAEs) | Count | From baseline (day 0) to end of study (month 36) | |
| Secondary | Change in glycosylated haemoglobin A1c (HbA1c) | Percent | From baseline (day 0) to end of study (month 36) | |
| Secondary | Change in fasting plasma glucose (FPG) | mg/dL | From baseline (day 0) to end of study (month 36) | |
| Secondary | Change in body weight | kg | From baseline (day 0) to end of study (month 36) | |
| Secondary | Change in patient-reported outcomes (PROs) using the Diabetes Therapy-Related QOL (DTR-QOL) questionnaire - total score | DTR-QOL assesses the influence of diabetes treatment on the individual health related quality of life on 4 domains: "burden on social activities and daily activities", "anxiety and dissatisfaction with treatment", "hypoglycaemia" and "satisfaction with treatment". DTR-QOL contains 29 items. The response scale used is a 7-point Likert scale (1:
Strongly agree - 7: Strongly disagree) |
From baseline (day 0) to visit 5 (month 12) | |
| Secondary | Change in patient-reported outcomes (PROs) using the Diabetes Therapy-Related QOL (DTR-QOL) questionnaire - burden of social activities and daily activities | DTR-QOL assesses the influence of diabetes treatment on the individual health related quality of life on 4 domains: "burden on social activities and daily activities", "anxiety and dissatisfaction with treatment", "hypoglycaemia" and "satisfaction with treatment". DTR-QOL contains 29 items. The response scale used is a 7-point Likert scale (1:
Strongly agree - 7: Strongly disagree) |
From baseline (day 0) to visit 5 (month 12) | |
| Secondary | Change in patient-reported outcomes (PROs) using the Diabetes Therapy-Related QOL (DTR-QOL) questionnaire - anxiety and dissatisfaction with treatment | DTR-QOL assesses the influence of diabetes treatment on the individual health related quality of life on 4 domains: "burden on social activities and daily activities", "anxiety and dissatisfaction with treatment", "hypoglycaemia" and "satisfaction with treatment". DTR-QOL contains 29 items. The response scale used is a 7-point Likert scale (1:
Strongly agree - 7: Strongly disagree) |
From baseline (day 0) to visit 5 (month 12) | |
| Secondary | Change in patient-reported outcomes (PROs) using the Diabetes Therapy-Related QOL (DTR-QOL) questionnaire - hypoglycaemia | DTR-QOL assesses the influence of diabetes treatment on the individual health related quality of life on 4 domains: "burden on social activities and daily activities", "anxiety and dissatisfaction with treatment", "hypoglycaemia" and "satisfaction with treatment". DTR-QOL contains 29 items. The response scale used is a 7-point Likert scale (1:
Strongly agree - 7: Strongly disagree) |
From baseline (day 0) to visit 5 (month 12) | |
| Secondary | Change in patient-reported outcomes (PROs) using the Diabetes Therapy-Related QOL (DTR-QOL) questionnaire - satisfaction with treatment | DTR-QOL assesses the influence of diabetes treatment on the individual health related quality of life on 4 domains: "burden on social activities and daily activities", "anxiety and dissatisfaction with treatment", "hypoglycaemia" and "satisfaction with treatment". DTR-QOL contains 29 items. The response scale used is a 7-point Likert scale (1:
Strongly agree - 7: Strongly disagree) |
From baseline (day 0) to visit 5 (month 12) |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |